AAAAAA
Results: 1-25/28
Authors:
Schachter, J
Stephens, RS
Timms, P
Kuo, C
Bavoil, PM
Birkelund, S
Boman, J
Caldwell, H
Campbell, LA
Chernesky, M
Christiansen, G
Clarke, IN
Gaydos, C
Grayston, JT
Hackstadt, T
Hsia, R
Kaltenboeck, B
Leinonnen, M
Ocjius, D
McClarty, G
Orfila, J
Peeling, R
Puolakkainen, M
Quinn, TC
Rank, RG
Raulston, J
Ridgeway, GL
Saikku, P
Stamm, WE
Taylor-Robinson, D
Wang, SP
Wyrick, PB
Citation: J. Schachter et al., Radical changes to chlamydial taxonomy are not necessary just yet, INT J SY EV, 51, 2001, pp. 249-249
Authors:
Dowell, SF
Peeling, RW
Boman, J
Carlone, GM
Fields, BS
Guarner, J
Hammerschlag, MR
Jackson, LA
Kuo, CC
Maass, M
Messmer, TO
Talkington, DF
Tondella, ML
Zaki, SR
Bandea, C
Black, C
O'Conner, S
Papp, J
Perilla, MJ
Schuchat, A
Stevens, V
Van Beneden, CA
Zell, ER
Cohen, C
Campbell, LA
Wwang, SP
Grayston, JT
Deal, CD
Gaydos, C
Schindler, L
Taylor, CE
Mahony, J
Fong, IW
Leinonen, M
Saikku, P
Maas, M
Ossewaarde, JM
Persson, K
Boman, J
Apfalter, P
Citation: Sf. Dowell et al., Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada), CLIN INF D, 33(4), 2001, pp. 492-502
Authors:
Sharma, N
Rutherford, JD
Grayston, JT
King, LP
Jialal, I
Andrews, TC
Citation: N. Sharma et al., Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults, AM J CARD, 87(1), 2001, pp. 119
Authors:
Jackson, LA
Cherry, JD
Wang, SP
Grayston, JT
Citation: La. Jackson et al., Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses, CLIN INF D, 31(1), 2000, pp. 3-6
Authors:
Jackson, LA
Wang, SP
Nazar-Stewart, V
Grayston, JT
Vaughan, TL
Citation: La. Jackson et al., Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer, CANC EPID B, 9(11), 2000, pp. 1263-1266
Authors:
Elkind, MSV
Lin, IF
Grayston, JT
Sacco, RL
Citation: Msv. Elkind et al., Chlamydia pneumoniae and the risk of first ischemic stroke - The Northern Manhattan Stroke Study, STROKE, 31(7), 2000, pp. 1521-1525
Authors:
Grayston, JT
Citation: Jt. Grayston, Background and current knowledge of Chlamydia pneumoniae and atherosclerosis, J INFEC DIS, 181, 2000, pp. S402-S410
Authors:
Siscovick, DS
Schwartz, SM
Caps, M
Wang, SP
Grayston, JT
Citation: Ds. Siscovick et al., Chlamydia pneumoniae and atherosclerotic risk in populations: The role of seroepidemiology, J INFEC DIS, 181, 2000, pp. S417-S420
Authors:
Peeling, RW
Wang, SP
Grayston, JT
Blasi, F
Boman, J
Clad, A
Freidank, H
Gaydos, CA
Gnarpe, J
Hagiwara, T
Jones, RB
Orfila, J
Persson, K
Puolakkainen, M
Saikku, P
Schachter, J
Citation: Rw. Peeling et al., Chlamydia pneumoniae serology: Interlaboratory variation in microimmunofluorescence assay results, J INFEC DIS, 181, 2000, pp. S426-S429
Authors:
Jackson, LA
Campbell, LA
Schmidt, RA
Kuo, CC
Cappuccio, AL
Lee, MJ
Grayston, JT
Citation: La. Jackson et al., Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma, J INFEC DIS, 181, 2000, pp. S447-S448
Authors:
Jackson, LA
Smith, NL
Heckbert, SR
Grayston, JT
Siscovick, DS
Psaty, BM
Citation: La. Jackson et al., Past use of erythromycin, tetracycline, or doxycycline is not associated with risk of first myocardial infarction, J INFEC DIS, 181, 2000, pp. S563-S565
Authors:
Grayston, JT
Citation: Jt. Grayston, What is needed to prove that Chlamydia pneumoniae does, or does not, play an etiologic role in atherosclerosis?, J INFEC DIS, 181, 2000, pp. S585-S586
Authors:
Siscovick, DS
Schwartz, SM
Corey, L
Grayston, JT
Ashley, R
Wang, SP
Psaty, BM
Tracy, RP
Kuller, LH
Kronmal, RA
Citation: Ds. Siscovick et al., Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus andincident myocardial infarction and coronary heart disease death in older adults - The Cardiovascular Health Study, CIRCULATION, 102(19), 2000, pp. 2335-2340
Authors:
Grayston, JT
Citation: Jt. Grayston, Secondary prevention antibiotic treatment trials for coronary artery disease, CIRCULATION, 102(15), 2000, pp. 1742-1743
Authors:
Vergis, EN
Indorf, A
File, TM
Phillips, J
Bates, J
Tan, J
Sarosi, GA
Grayston, JT
Summersgill, J
Yu, VL
Citation: En. Vergis et al., Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients - A prospective, randomized, multicenter trial, ARCH IN MED, 160(9), 2000, pp. 1294-1300
Authors:
Jackson, LA
Smith, NL
Heckbert, SR
Grayston, JT
Siscovick, DS
Psaty, BM
Citation: La. Jackson et al., Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline, EM INFECT D, 5(2), 1999, pp. 281-284
Authors:
Grayston, JT
Campbell, LA
Citation: Jt. Grayston et La. Campbell, The role of Chlamydia pneumoniae in atherosclerosis - Editorial response, CLIN INF D, 28(5), 1999, pp. 993-994
Authors:
Grayston, JT
Citation: Jt. Grayston, Tracking the TWAR organism, INF DIS C P, 8(1), 1999, pp. 41-44
Authors:
Jackson, LA
Stewart, DK
Wang, SP
Cooke, DB
Cantrell, T
Grayston, JT
Citation: La. Jackson et al., Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease, J ANTIMICRO, 44(3), 1999, pp. 411-414
Authors:
Moazed, TC
Campbell, LA
Rosenfeld, ME
Grayston, JT
Kuo, CC
Citation: Tc. Moazed et al., Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice, J INFEC DIS, 180(1), 1999, pp. 238-241
Authors:
Grayston, JT
Citation: Jt. Grayston, Antibiotic treatment trials for secondary prevention of coronary artery disease events, CIRCULATION, 99(12), 1999, pp. 1538-1539
Authors:
Grayston, JT
Citation: Jt. Grayston, Does Chlamydia pneumoniae cause atherosclerosis?, ARCH SURG, 134(9), 1999, pp. 930-934
Authors:
Nieto, FJ
Folsom, AR
Sorlie, PD
Grayston, JT
Wang, SP
Chambless, LE
Citation: Fj. Nieto et al., Chlamydia pneumoniae infection and incident coronary heart disease - The Atherosclerosis Risk in Communities Study, AM J EPIDEM, 150(2), 1999, pp. 149-156
Authors:
Zhou, YF
Csako, G
Grayston, JT
Wang, SP
Yu, ZX
Shou, M
Leon, M
Epstein, SE
Citation: Yf. Zhou et al., Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae, AM J CARD, 84(5), 1999, pp. 595
Authors:
Grayston, JT
Jackson, LA
Kennedy, WJ
Kronmal, RA
Citation: Jt. Grayston et al., Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: Design issues, AM HEART J, 138(5), 1999, pp. S545-S549